Protein kinase D stabilizes aldosterone-induced ERK1/2 MAP kinase activation in M1 renal cortical collecting duct cells to promote cell proliferation

Journal of Steroid Biochemistry and Molecular Biology

Volumn 118, Issue 1-2, 2010, Pages 18-28

  McEneaney, Victoria ^a   Dooley, Ruth ^a   Harvey, Brian J ^a   Thomas, Warren ^a  

^a ROYAL COLLEGE OF SURGEONS IN IRELAND   (Ireland)

Author keywords

Aldosterone; Cell proliferation; Kidney; MAPK; PKD1

Indexed keywords

ALDOSTERONE; EPIDERMAL GROWTH FACTOR RECEPTOR; MINERALOCORTICOID RECEPTOR; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; OXPRENOATE POTASSIUM; PROTEIN KINASE D;

ANIMAL CELL; APOPTOSIS; ARTICLE; CELL PROLIFERATION; CELL STIMULATION; CONFOCAL MICROSCOPY; CONTROLLED STUDY; CYTOPLASM; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME LOCALIZATION; ENZYME STABILITY; IMMUNOFLUORESCENCE; IMMUNOPRECIPITATION; KIDNEY CORTEX; MOUSE; NONHUMAN; POLYACRYLAMIDE GEL ELECTROPHORESIS; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; SIGNAL TRANSDUCTION; WESTERN BLOTTING;

ACETOPHENONES; ACTIVE TRANSPORT, CELL NUCLEUS; ALDOSTERONE; ALDOSTERONE ANTAGONISTS; ANIMALS; BENZOPYRANS; CELL LINE; CELL PROLIFERATION; CYTOPLASM; ENZYME ACTIVATION; EPITHELIAL CELLS; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; FLAVONOIDS; KIDNEY CORTEX; KIDNEY TUBULES, COLLECTING; MICE; MITOGEN-ACTIVATED PROTEIN KINASE 1; MITOGEN-ACTIVATED PROTEIN KINASE 3; MODELS, BIOLOGICAL; PHOSPHORYLATION; PROTEIN BINDING; PROTEIN KINASE C-DELTA; PROTEIN KINASE INHIBITORS; RECEPTOR, EPIDERMAL GROWTH FACTOR; RECEPTORS, MINERALOCORTICOID; SIGNAL TRANSDUCTION; SPIRONOLACTONE; TRPP CATION CHANNELS; TYRPHOSTINS;

EID: 72449121310     PISSN: 09600760     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jsbmb.2009.09.014     Document Type: Article

References (53)

1. Booth R.E., Johnson J.P., and Stockand J.D. Aldosterone. Adv. Physiol. Educ. 26 1-4 (2002) 8-20
2. Gumz M.L., Popp M.P., Wingo C.S., and Cain B.D. Early transcriptional effects of aldosterone in a mouse inner medullary collecting duct cell line. Am. J. Physiol. Renal. Physiol. 285 4 (2003) F664-673
3. Robert-Nicoud M., Flahaut M., Elalouf J.M., Nicod M., Salinas M., Bens M., Doucet A., Wincker P., Artiguenave F., Horisberger J.D., Vandewalle A., Rossier B.C., and Firsov D. Transcriptome of a mouse kidney cortical collecting duct cell line: effects of aldosterone and vasopressin. Proc. Natl. Acad. Sci. U.S.A. 98 5 (2001) 2712-2716
4. Nishiyama A., Yao L., Fan Y., Kyaw M., Kataoka N., Hashimoto K., Nagai Y., Nakamura E., Yoshizumi M., Shokoji T., Kimura S., Kiyomoto H., Tsujioka K., Kohno M., Tamaki T., Kajiya F., and Abe Y. Involvement of aldosterone and mineralocorticoid receptors in rat mesangial cell proliferation and deformability. Hypertension 45 4 (2005) 710-716
5. Terada Y., Kobayashi T., Kuwana H., Tanaka H., Inoshita S., Kuwahara M., and Sasaki S. Aldosterone stimulates proliferation of mesangial cells by activating mitogen-activated protein kinase 1/2, cyclin D1, and cyclin A. J. Am. Soc. Nephrol. 16 8 (2005) 2296-2305
6. Xiao F., Puddefoot J.R., and Vinson G.P. Aldosterone mediates angiotensin II-stimulated rat vascular smooth muscle cell proliferation. J. Endocrinol. 165 2 (2000) 533-536
7. Campbell S.E., Janicki J.S., and Weber K.T. Temporal differences in fibroblast proliferation and phenotype expression in response to chronic administration of angiotensin II or aldosterone. J. Mol. Cell Cardiol. 27 8 (1995) 1545-1560
8. Tsybouleva N., Zhang L., Chen S., Patel R., Lutucuta S., Nemoto S., DeFreitas G., Entman M., Carabello B.A., Roberts R., and Marian A.J. Aldosterone, through novel signaling proteins, is a fundamental molecular bridge between the genetic defect and the cardiac phenotype of hypertrophic cardiomyopathy. Circulation 109 10 (2004) 1284-1291
9. Thomas W., McEneaney V., and Harvey B.J. Rapid responses to steroid hormones in the kidney. Nephron. Physiol. 107 1 (2007) 1-9
10. Sinnett-Smith J., Zhukova E., Hsieh N., Jiang X., and Rozengurt E. Protein kinase D potentiates DNA synthesis induced by Gq-coupled receptors by increasing the duration of ERK signaling in swiss 3T3 cells. J. Biol. Chem. 279 16 (2004) 16883-16893
11. Michlig S., Mercier A., Doucet A., Schild L., Horisberger J.D., Rossier B.C., and Firsov D. ERK1/2 controls Na,K-ATPase activity and transepithelial sodium transport in the principal cell of the cortical collecting duct of the mouse kidney. J. Biol. Chem. 279 49 (2004) 51002-51012
12. Rozengurt E., Rey O., and Waldron R.T. Protein kinase D signaling. J. Biol. Chem. 280 14 (2005) 13205-13208
13. Markos F., Healy V., and Harvey B.J. Aldosterone rapidly activates Na+/H+ exchange in M-1 cortical collecting duct cells via a PKC-MAPK pathway. Nephron. Physiol. 99 1 (2005) p1-9
14. Rossol-Haseroth K., Zhou Q., Braun S., Boldyreff B., Falkenstein E., Wehling M., and Losel R.M. Mineralocorticoid receptor antagonists do not block rapid ERK activation by aldosterone. Biochem. Biophys. Res. Commun. 318 1 (2004) 281-288
15. Gekle M., Freudinger R., Mildenberger S., and Silbernagl S. Rapid actions of aldosterone on cells from renal epithelium: the possible role of EGF-receptor signaling. Steroids 67 6 (2002) 499-504
16. Gregoire J.R., Torres V.E., Holley K.E., and Farrow G.M. Renal epithelial hyperplastic and neoplastic proliferation in autosomal dominant polycystic kidney disease. Am. J. Kidney Dis. 9 1 (1987) 27-38
17. Al-Bhalal L., and Akhtar M. Molecular basis of autosomal recessive polycystic kidney disease (ARPKD). Adv. Anat. Pathol. 15 1 (2008) 54-58
18. Ward C.J., Turley H., Ong A.C., Comley M., Biddolph S., Chetty R., Ratcliffe P.J., Gattner K., and Harris P.C. Polycystin, the polycystic kidney disease 1 protein, is expressed by epithelial cells in fetal, adult, and polycystic kidney. Proc. Natl. Acad. Sci. U.S.A. 93 4 (1996) 1524-1528
19. Yates-Bell J.G. Hypertension in polycystic disease. Br. J. Urol. 29 4 (1957) 371-373
20. Masoumi A., Reed-Gitomer B., Kelleher C., and Schrier R.W. Potential pharmacological interventions in polycystic kidney disease. Drugs 67 17 (2007) 2495-2510
21. McEneaney V., Harvey B.J., and Thomas W. Aldosterone rapidly activates protein kinase D via a mineralocorticoid receptor/EGFR trans-activation pathway in the M1 kidney CCD cell line. J. Steroid Biochem. Mol. Biol. 107 3-5 (2007) 180-190
22. Stoos B.A., Naray-Fejes-Toth A., Carretero O.A., Ito S., and Fejes-Toth G. Characterization of a mouse cortical collecting duct cell line. Kidney Int. 39 6 (1991) 1168-1175
23. Korbmacher C., Segal A.S., Fejes-Toth G., Giebisch G., and Boulpaep E.L. Whole-cell currents in single and confluent M-1 mouse cortical collecting duct cells. J. Gen. Physiol. 102 4 (1993) 761-793
24. McEneaney V., Harvey B.J., and Thomas W. Aldosterone regulates rapid trafficking of epithelial sodium channel subunits in renal cortical collecting duct cells via protein kinase D activation. Mol. Endocrinol. 22 4 (2008) 881-892
25. Kato S., Endoh H., Masuhiro Y., Kitamoto T., Uchiyama S., Sasaki H., Masushige S., Gotoh Y., Nishida E., Kawashima H., Metzger D., and Chambon P. Activation of the estrogen receptor through phosphorylation by mitogen-activated protein kinase. Science 270 5241 (1995) 1491-1494
26. Le Moellic C., Ouvrard-Pascaud A., Capurro C., Cluzeaud F., Fay M., Jaisser F., Farman N., and Blot-Chabaud M. Early nongenomic events in aldosterone action in renal collecting duct cells: PKCalpha activation, mineralocorticoid receptor phosphorylation, and cross-talk with the genomic response. J. Am. Soc. Nephrol. 15 5 (2004) 1145-1160
27. Gekle M., Freudinger R., Mildenberger S., Schenk K., Marschitz I., and Schramek H. Rapid activation of Na+/H+-exchange in MDCK cells by aldosterone involves MAP-kinase ERK1/2. Pflugers Arch. 441 6 (2001) 781-786
28. Horikoshi S., Kubota S., Martin G.R., Yamada Y., and Klotman P.E. Epidermal growth factor (EGF) expression in the congenital polycystic mouse kidney. Kidney Int. 39 1 (1991) 57-62
29. Chen R.H., Sarnecki C., and Blenis J. Nuclear localization and regulation of erk- and rsk-encoded protein kinases. Mol. Cell. Biol. 12 3 (1992) 915-927
30. Turjanski A.G., Vaque J.P., and Gutkind J.S. MAP kinases and the control of nuclear events. Oncogene 26 22 (2007) 3240-3253
31. Lenormand P., Sardet C., Pages G., L'Allemain G., Brunet A., and Pouyssegur J. Growth factors induce nuclear translocation of MAP kinases (p42mapk and p44mapk) but not of their activator MAP kinase kinase (p45mapkk) in fibroblasts. J. Cell. Biol. 122 5 (1993) 1079-1088
32. Adachi M., Fukuda M., and Nishida E. Nuclear export of MAP kinase (ERK) involves a MAP kinase kinase (MEK)-dependent active transport mechanism. J. Cell. Biol. 148 5 (2000) 849-856
33. Chrysostomou A., and Becker G. Spironolactone in addition to ACE inhibition to reduce proteinuria in patients with chronic renal disease. N. Engl. J. Med. 345 12 (2001) 925-926
34. Nishiyama A., Yao L., Nagai Y., Miyata K., Yoshizumi M., Kagami S., Kondo S., Kiyomoto H., Shokoji T., Kimura S., Kohno M., and Abe Y. Possible contributions of reactive oxygen species and mitogen-activated protein kinase to renal injury in aldosterone/salt-induced hypertensive rats. Hypertension 43 4 (2004) 841-848
35. Minuth W.W., Denk L., and Hu K. The role of polyester interstitium and aldosterone during structural development of renal tubules in serum-free medium. Biomaterials 28 30 (2007) 4418-4428
36. L'Allemain G., Paris S., and Pouyssegur J. Growth factor action and intracellular pH regulation in fibroblasts. Evidence for a major role of the Na+/H+ antiport. J. Biol. Chem. 259 9 (1984) 5809-5815
37. 2+ increase and alkalinization correlate with epidermal-growth-factor-induced cell proliferation. Biochem. J. 254 1 (1988) 223-228
38. Hendron E., and Stockand J.D. Activation of mitogen-activated protein kinase (mitogen-activated protein kinase/extracellular signal-regulated kinase) cascade by aldosterone. Mol. Biol. Cell. 13 9 (2002) 3042-3054
39. Chen S.Y., Wang J., Liu W., and Pearce D. Aldosterone responsiveness of A6 cells is restored by cloned rat mineralocorticoid receptor. Am. J. Physiol. 274 1 Pt 1 (1998) C39-46
40. Keshamouni V.G., Mattingly R.R., and Reddy K.B. Mechanism of 17-beta-estradiol-induced Erk1/2 activation in breast cancer cells. A role for HER2 AND PKC-delta. J. Biol. Chem. 277 25 (2002) 22558-22565
41. Ginnan R., and Singer H.A. PKC-delta-dependent pathways contribute to PDGF-stimulated ERK1/2 activation in vascular smooth muscle. Am. J. Physiol. Cell. Physiol. 288 6 (2005) C1193-1201
42. Grossmann C., Benesic A., Krug A.W., Freudinger R., Mildenberger S., Gassner B., and Gekle M. Human mineralocorticoid receptor expression renders cells responsive for nongenotropic aldosterone actions. Mol. Endocrinol. 19 7 (2005) 1697-1710
43. Grantcharova E., Reusch H.P., Beyermann M., Rosenthal W., and Oksche A. Endothelin A and endothelin B receptors differ in their ability to stimulate ERK1/2 activation. Exp. Biol. Med. (Maywood) 231 6 (2006) 757-760
44. Wang H., Doronin S., and Malbon C.C. Insulin activation of mitogen-activated protein kinases Erk1,2 is amplified via beta-adrenergic receptor expression and requires the integrity of the Tyr350 of the receptor. J. Biol. Chem. 275 46 (2000) 36086-36093
45. Braun S., Losel R., Wehling M., and Boldyreff B. Aldosterone rapidly activates Src kinase in M-1 cells involving the mineralocorticoid receptor and HSP84. FEBS Lett. 570 1-3 (2004) 69-72
46. Sinnett-Smith J., Zhukova E., Rey O., and Rozengurt E. Protein kinase D2 potentiates MEK/ERK/RSK signaling, c-Fos accumulation and DNA synthesis induced by bombesin in Swiss 3T3 cells. J. Cell. Physiol. 211 3 (2007) 781-790
47. Brandlin I., Hubner S., Eiseler T., Martinez-Moya M., Horschinek A., Hausser A., Link G., Rupp S., Storz P., Pfizenmaier K., and Johannes F.J. Protein kinase C (PKC)eta-mediated PKC mu activation modulates ERK and JNK signal pathways. J. Biol. Chem. 277 8 (2002) 6490-6496
48. Nadasdy T., Laszik Z., Lajoie G., Blick K.E., Wheeler D.E., and Silva F.G. Proliferative activity of cyst epithelium in human renal cystic diseases. J. Am. Soc. Nephrol. 5 7 (1995) 1462-1468
49. Yang J., Zhang S., Zhou Q., Guo H., Zhang K., Zheng R., and Xiao C. PKHD1 gene silencing may cause cell abnormal proliferation through modulation of intracellular calcium in autosomal recessive polycystic kidney disease. J. Biochem. Mol. Biol. 40 4 (2007) 467-474
50. MacRae Dell K., Nemo R., Sweeney Jr. W.E., and Avner E.D. EGF-related growth factors in the pathogenesis of murine ARPKD. Kidney Int. 65 6 (2004) 2018-2029
51. Danielsen H., Pedersen E.B., Nielsen A.H., Herlevsen P., Kornerup H.J., and Posborg V. Expansion of extracellular volume in early polycystic kidney disease. Acta Med. Scand. 219 4 (1986) 399-405
52. Chapman A.B. Approaches to testing new treatments in autosomal dominant polycystic kidney disease: insights from the CRISP and HALT-PKD studies. Clin. J. Am. Soc. Nephrol. 3 4 (2008) 1197-1204
53. Naray-Fejes-Toth A., and Fejes-Toth G. The sgk, an aldosterone-induced gene in mineralocorticoid target cells, regulates the epithelial sodium channel. Kidney Int. 57 4 (2000) 1290-1294